Abstract
he article presents the results of the study of C-reactive protein, interleukin-6, tumor necrosis factor-α and interleukin-10 levels in postmyocardial infarction patients with type 2 diabetes mellitus. It was identified significantly higher concentrations of C-reactive protein, proinflammatory interleukin-6 and tumor necrosis factor-α and anti-inflammatory interleukin-10 in comparison with the control group. The study found that the combination of postinfarction cardiosclerosis and type 2 diabetes mellitus shows higher degree of activity of markers of systemic inflammation than in isolated course of disease, when identical anti-inflammatory protection. The data shows that the blood glucose levels directly affect the concentration of C-reactive protein and interleukin-10, whereas insulin resistance directly depends on the activity of inflammation markers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
